Evidence map›Paper›PMID 42457334›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2026

[Clinical diagnosis and treatment of four cases of Castleman disease in children].

Pei-Qun Wu, Hong-Li Wang, Li-Ya Xiong, Si-Tang Gong, Lan-Lan Geng

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pei-Qun WuDepartment of Gastroenterology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China.
Hong-Li WangDepartment of Gastroenterology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China.
Li-Ya XiongDepartment of Gastroenterology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China.
Si-Tang GongDepartment of Gastroenterology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China.
Lan-Lan GengDepartment of Gastroenterology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical diagnosis and treatment processes of four children with Castleman disease admitted to Guangzhou Women and Children's Medical Center, Guangzhou Medical University, from March 2021 to December 2024 were retrospectively analyzed. Among them, three cases were unicentric Castleman disease, presenting as abdominal pain with ileocecal ulceration, concomitant classical Hodgkin lymphoma, and choledochal cyst, respectively. One case was severe idiopathic multicentric Castleman disease involving lymph nodes in the neck and axillary regions, presenting with fever, abdominal distension, generalized edema, fatigue, anemia, hepatic dysfunction, polyserous effusion, and other systemic manifestations. The three unicentric cases underwent complete surgical resection of enlarged lymph nodes. The case with abdominal pain received subsequent enteral nutrition and oral thalidomide therapy. The case complicated with Hodgkin lymphoma received chemotherapy according to the Hodgkin lymphoma protocol. The severe multicentric case was treated with rituximab combined with vincristine, pirarubicin, cyclophosphamide, and prednisone. All four cases achieved complete remission during 6 to 30 months of follow-up. Clinical manifestations of Castleman disease in children lack specificity. Surgical resection remains the main treatment for unicentric cases, while treatment regimens for multicentric cases are more varied. The overall prognosis is favorable. Further studies are needed to determine the optimal treatment for Castleman disease complicated by gastrointestinal ulcers and severe idiopathic multicentric Castleman disease.

Indexed as

Castleman DiseaseChildFemaleHumansMaleRetrospective StudiesCastleman diseaseChildGastrointestinal ulcerTreatment

Identifiers

PMID42457334
PMCPMC13372544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.